Rigel to Present at the Jefferies Global Healthcare Conference

Rhea-AI Summary

Rigel Pharmaceuticals (Nasdaq: RIGL) announced that its president and CEO, Raul Rodriguez, will present a company overview at the Jefferies Global Healthcare Conference on June 6, 2024, at 9:30 am ET in New York, NY.

The presentation will be available via live webcast on Rigel's Investor Relations website.

Founded in 1996 and based in South San Francisco, Rigel focuses on developing therapies for hematologic disorders and cancer. For more information, visit www.rigel.com.

Positive

• Rigel's participation at Jefferies Global Healthcare Conference may increase visibility among investors and stakeholders.
• Opportunity to present recent developments in hematologic and cancer therapies.

Negative

• No new clinical or financial data disclosed in the PR.
• Potential investors might find the PR lacking in detailed business updates or performance metrics.

SOUTH SAN FRANCISCO, Calif., May 30, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:30 am ET in New York, NY.

To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.

Contact for Investors & Media:

Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com 

Media:
David Rosen
Argot Partners
Phone: 212.600.1902
Email: david.rosen@argotpartners.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-jefferies-global-healthcare-conference-302158864.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

When will Rigel Pharmaceuticals present at the Jefferies Global Healthcare Conference?

Rigel Pharmaceuticals will present on June 6, 2024, at 9:30 am ET.

Who will present Rigel Pharmaceuticals' overview at the Jefferies Global Healthcare Conference?

Raul Rodriguez, the president and CEO of Rigel Pharmaceuticals, will present the overview.

How can I access the Rigel Pharmaceuticals presentation at the Jefferies Global Healthcare Conference?

The presentation will be available via live webcast on the Investor Relations section of Rigel's website.

What is the focus of Rigel Pharmaceuticals?

Rigel Pharmaceuticals focuses on developing novel therapies for hematologic disorders and cancer.